Ning Zhu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Revolutionary ctDNA-Guided Therapy Adaptation in ESR1-Mutated Advanced Breast Cancer: Insights from the Initial SERENA-6 Trial.
Journal: Cancer communications (London, England)
Published: November 13, 2025
Targeting EP2/EP4-driven expansion of suppressive VSIG4high macrophages overcomes immunotherapy resistance in colorectal cancer.
Journal: Cell reports
Published: September 13, 2025
The ubiquitin code of RAS proteins: Decoding its role in cancer progression.
Journal: iScience
Published: July 24, 2025
An IL-6-induced STAT3-to-PI3K signaling switch potently drives PD-L1 transcription in cancer stem cells of colorectal cancer.
Journal: Science bulletin
Published: March 04, 2025
Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget's disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget's disease patients.
Journal: Cancer immunology, immunotherapy : CII
Published: August 07, 2024
Exciting progress in targeted therapy innovation for unresectable stage III EGFR-mutated NSCLC: the phase III LAURA study.
Journal: Cancer communications (London, England)
Published: June 25, 2024
New advances in noninvasive screening technology for colorectal cancer.
Journal: MedComm
Published: June 23, 2024
Genetic and microbial determinants of azoxymethane-induced colorectal tumor susceptibility in Collaborative Cross mice and their implication in human cancer.
Journal: Gut microbes
Published: April 25, 2024
Loss-of-function mutation of REV1 (p.R704Q) mediates cetuximab primary resistance by activating autophagy in RAS-wild type metastatic colorectal cancer.
Journal: Cancer letters
Published: January 11, 2024
Immunotherapy combined with local therapy in the late-line treatment of repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer.
Journal: Heliyon
Published: October 19, 2023
Global burden of tracheal, bronchus, and lung cancer attributable to occupational carcinogens in 204 countries and territories, from 1990 to 2019: results from the global burden of disease study 2019.
Journal: Annals of medicine
Published: May 08, 2023
Last Updated: 09/26/2026